in 1990's, CLDX stock was $250... look at the chart before open your mouth again.. CLDX has been in the cancer curing business for the past 30 years.. they keep re-branding themselves every 10 years after stock price had collapsed.. apparently many of these pumpers have never seen the CLDX stock chart, nor understanding how the black pool works.
MW, bogus law firms released these bogus lawsuits to recruit clients, and SA is right behind it to release bogus articles in the attempt manipulating stock price... SEC should step up their efforts to protect their members from financial terrorism..
understanding the history of the CLDX numerous failures. The bottom line is, it could happen again because CLDX is still partnering and licensing from these big pharma devils ..
CLDX has research collaboration and license agreements with Medarex, Inc.; Rockefeller University; Duke University Brain Tumor Cancer Center; Ludwig Institute for Cancer Research; Thomas Jefferson University; University of Southampton; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc.
CDLX had announced "Plastics" in 1986, 1990, 2000, and now 2013... each time, new suckers have poured money into the pit and realizing that no FDA approval = no drugs = no revs. Eventually CLDX stock pulled back to the zero revs level, awaiting for the new trend to re-branding themselves. CLDX was found in 1983, and for the last 30yrs of research, they have not made a dime for the products that they were researched for...
Fool Me Once, Shame On me, Fool Me Twice,Shame on Me,Fool Me the third time...Shame on You??"
He switched wrong medication today.. instead of taking Viagra, he took Midol.. a little crankie today heh ?
using scientific approach to demonstrate basic logic is a major intellectual challenges for many posters on this board. All hypes, a lot of hopes and baseless speculation. Disagreement is healthy, but I haven't seen any because none of the poster shows their numbers that prove my math is incorrect.
Speaking of spending too much time explaining to dummies about CLDX, bsacoor, you need to tell posters on franzie's resignation of an msnbc employee... because it has nothing to do with the CLDX stock.. at least my post focuses on CLDX fundamentals.
dbegley, which is bigger number: $240mil or $171.5 mil...wonder why many companies could not find qualified candidates to fill opening positions due to lack of math and science.. you have proven they were right...cash is asset, but market caps is NOT ?? would you transfer your checking account to me if I give you 71 cents cash for every dollar in your account ??
the only fuzzy is your mumble jumble about buying at $2..blah blah blah.. where is your math proving this secondary is good for share holders and investors... show your math skills, don't reference the last offer because you're only cherry picking the timelines to mislead the facts. Speaking of the LT investments, CLDX is in existence for 30 yrs, they have raised cash for numerous of times and stock used to trade at $200ish.. If you started investing in 2007, then show me how many drugs did CLDX release to the market and the revenues came from those drugs ?? if you're an investor who would hang on with a company that produces nothing for 6 yrs, then I REST MY CASE....
Let me tell you why:
CLDX was traded at $27.50 when the secondary offering announcement, 80 Mil. floated shares. Secondary offer of 7mil shares priced at $24.50.
The market cap loss of $3 X 80 mil shares = (- $240 Mil.)
Cash gain from $24.5 X 7 Mil. shares = + $171.5 Mil.
Investors loss $240 Mil. while CLDX gains $171.5 Mil. in cash. Basically CLDX management says, screw investors..
If CLDX has a such potential pipeline of products, why don't they raise cash through private equity firms by selling 7 Mil shares at 10% discount ($24.5) without interfering with the floated shares ? I am suspected that private equity firms are too smart to invest in bogus claims by CLDX's phase I, II trials results.. it is easier to screw these retail investors and lazy institutional investors who managed public money like 401K, IRA , Pension plans.. you don't have to agree with me, just do the math and you can see the discrepancies of the net gain/loss of this transaction... who is in the right mind would lose $240 Mil in market caps to gain $171.5 Mil in cash ???
apparently CLDX can fool some of the people, all the time and you're one of them...
CLDX has been in cancer curing business for the past 30yrs, and every secondary offering would be the last until the next one... no product is in the market, but money was raised for acquisitions, or operation, or critical trials, or BSing reasons why cash is needed.. at the end of the day, no product, no revs, no cancer cured, and senior management team will resign, and they will re-started over with a new theme, new potential drugs, new research,, new trials, new management teams.. and they will find new suckers who have never been in the rodeo before.. willing to invest in the new scheme... good luck...
CLDX needs to establish baseline products as a revenue generator while exploring other potential cure.. it appears that CLDX is trying to do too much at the same time and all it takes just a one fail, the whole pipeline will collapsed and no revenue to recover..a finite (limited) resources and lack of focus could turn my investments into "all or none" scenario, trying to stay positive but I have to re-evaluate my risk exposure here..
US market is a rigged game.. manipulation is normal, pre-market pricing is out of control. SEC= Scam Exchanges Central.
media is owned by a small group of people, they only published one-sided's view to advance their agenda.. corrupted politicians only made laws in favor of them.. Americans are so busy working to pay bills, taxes, and contributing to their retirements, unfortunately they controlled all the financial systems too.
stephen,your mom bought it @ 14.75, she thought it was 14.75 inch.. she gobbled the whole thang, so you won't see it again...
based on the WS reports: Investors agreed to receive no income from the hybrid instruments in exchange for the right to get Yahoo shares or cash if the stock price jumps 50%. Yahoo's conversion kicks in at 50% above the current market price, or at $53.43 a share. That is a higher threshold than ServiceNow and Microsoft had, whose notes could convert at 37.5% and 33%, respectively.
The terms are favorable to Yahoo. It doesn't have to make regular payments to holders of the notes and doesn't have to issue any new shares until the stock price rises substantially.
should be 5M shares traded before mkt open.. YHOO USA has zero value when stock is under $50. Alibaba valued at $45, and Yhoo Japan #$%$ .. 0% senior convertible note could turn YHOO into zero debts with $5Bil in cash. you don't need to be a financial genius to decide by getting $30 (YHOO USA) intrinsic value for free.. it should be traded @$40 by Friday this week..